The effect of COVID-19 on public hospital revenues in Iran: An interrupted time-series analysis.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
23
09
2021
accepted:
19
03
2022
entrez:
31
3
2022
pubmed:
1
4
2022
medline:
15
4
2022
Statut:
epublish
Résumé
The "Coronavirus Disease 2019" (COVID-19) pandemic has become a major challenge for all healthcare systems worldwide, and besides generating a high toll of deaths, it has caused economic losses. Hospitals have played a key role in providing services to patients and the volume of hospital activities has been refocused on COVID-19 patients. Other activities have been limited/repurposed or even suspended and hospitals have been operating with reduced capacity. With the decrease in non-COVID-19 activities, their financial system and sustainability have been threatened, with hospitals facing shortage of financial resources. The aim of this study was to investigate the effects of COVID-19 on the revenues of public hospitals in Lorestan province in western Iran, as a case study. In this quasi-experimental study, we conducted the interrupted time series analysis to evaluate COVID-19 induced changes in monthly revenues of 18 public hospitals, from April 2018 to August 2021, in Lorestan, Iran. In doing so, public hospitals report their earnings to the University of Medical Sciences monthly; then, we collected this data through the finance office. Due to COVID-19, the revenues of public hospitals experienced an average monthly decrease of $172,636 thousand (P-value = 0.01232). For about 13 months, the trend of declining hospital revenues continued. However, after February 2021, a relatively stable increase could be observed, with patient admission and elective surgeries restrictions being lifted. The average monthly income of hospitals increased by $83,574 thousand. COVID-19 has reduced the revenues of public hospitals, which have faced many problems due to the high costs they have incurred. During the crisis, lack of adequate fundings can damage healthcare service delivery, and policymakers should allocate resources to prevent potential shocks.
Sections du résumé
BACKGROUND
The "Coronavirus Disease 2019" (COVID-19) pandemic has become a major challenge for all healthcare systems worldwide, and besides generating a high toll of deaths, it has caused economic losses. Hospitals have played a key role in providing services to patients and the volume of hospital activities has been refocused on COVID-19 patients. Other activities have been limited/repurposed or even suspended and hospitals have been operating with reduced capacity. With the decrease in non-COVID-19 activities, their financial system and sustainability have been threatened, with hospitals facing shortage of financial resources. The aim of this study was to investigate the effects of COVID-19 on the revenues of public hospitals in Lorestan province in western Iran, as a case study.
METHOD
In this quasi-experimental study, we conducted the interrupted time series analysis to evaluate COVID-19 induced changes in monthly revenues of 18 public hospitals, from April 2018 to August 2021, in Lorestan, Iran. In doing so, public hospitals report their earnings to the University of Medical Sciences monthly; then, we collected this data through the finance office.
RESULTS
Due to COVID-19, the revenues of public hospitals experienced an average monthly decrease of $172,636 thousand (P-value = 0.01232). For about 13 months, the trend of declining hospital revenues continued. However, after February 2021, a relatively stable increase could be observed, with patient admission and elective surgeries restrictions being lifted. The average monthly income of hospitals increased by $83,574 thousand.
CONCLUSION
COVID-19 has reduced the revenues of public hospitals, which have faced many problems due to the high costs they have incurred. During the crisis, lack of adequate fundings can damage healthcare service delivery, and policymakers should allocate resources to prevent potential shocks.
Identifiants
pubmed: 35358279
doi: 10.1371/journal.pone.0266343
pii: PONE-D-21-30747
pmc: PMC8970352
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0266343Déclaration de conflit d'intérêts
All authors declare that there are no conflicts of interest.
Références
Front Public Health. 2020 Jul 03;8:347
pubmed: 32719765
Med J Islam Repub Iran. 2018 May 12;32:39
pubmed: 30159290
PLoS One. 2021 Jan 22;16(1):e0245586
pubmed: 33481900
J Eval Clin Pract. 2011 Dec;17(6):1231-8
pubmed: 20973870
BMJ. 2013 May 14;346:f2674
pubmed: 23674137
Int J Health Serv. 2020 Oct;50(4):396-407
pubmed: 32515260
Ann Ig. 2021 Jan-Feb;33(1):103-104
pubmed: 33354700
JAMA. 2020 May 12;323(18):1773-1774
pubmed: 32219367
BMC Health Serv Res. 2021 Feb 24;21(1):174
pubmed: 33627115
Yale J Biol Med. 2021 Mar 31;94(1):13-21
pubmed: 33795979
Iran J Pharm Res. 2020 Spring;19(2):1-8
pubmed: 33224206
Int J Epidemiol. 2017 Feb 1;46(1):348-355
pubmed: 27283160
BMJ. 2015 Jun 09;350:h2750
pubmed: 26058820
BMC Health Serv Res. 2021 Jul 23;21(1):731
pubmed: 34301264
J Med Virol. 2020 Apr;92(4):401-402
pubmed: 31950516
BMC Health Serv Res. 2021 Feb 11;21(1):132
pubmed: 33573650
Cost Eff Resour Alloc. 2020 Jun 29;18:20
pubmed: 32612458
Int J Health Plann Manage. 2020 Jan;35(1):339-345
pubmed: 31637776
Int J Health Policy Manag. 2017 Feb 11;6(10):573-586
pubmed: 28949473
Health Care Manag Sci. 2014 Dec;17(4):331-47
pubmed: 24338279
J Gen Intern Med. 2020 Sep;35(9):2760-2762
pubmed: 32607930
BMC Health Serv Res. 2020 Apr 19;20(1):327
pubmed: 32306975
JAMA. 2020 Jun 2;323(21):2127-2128
pubmed: 32364565
BMC Health Serv Res. 2021 Jul 26;21(1):740
pubmed: 34311716
J Prev Med Hyg. 2021 Jan 14;61(4):E508-E519
pubmed: 33628954
Br J Clin Pharmacol. 2017 Mar;83(3):642-652
pubmed: 27730670
BMC Pediatr. 2020 Sep 7;20(1):427
pubmed: 32894080
Int J Equity Health. 2020 May 6;19(1):61
pubmed: 32375787
PLoS One. 2021 Feb 17;16(2):e0247155
pubmed: 33596262
J Gen Intern Med. 2020 Sep;35(9):2807-2809
pubmed: 32607935